Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Craft

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Pediatric Blood & Cancer|May 10, 2017
Reply to reported missing founding member of the International Society of Paediatric Oncology …foundGiorgio Perilongo, Giulio D'Angio, Alan Craft, et al.
Pediatric Hematology and Oncology|February 3, 2012
Ewing sarcoma: clinical state-of-the-artJenny Potratz, Uta Dirksen, Heribert Jürgens, et al.
Pediatric Hematology and Oncology|February 7, 2012
Ewing sarcoma: biology-based therapeutic perspectivesJenny Potratz, Heribert Jürgens, Alan Craft, et al.
Archives of Disease in Childhood|March 8, 2016
Evidence for a delay in diagnosis of Wilms' tumour in the UK compared with Germany: implications for primary care for childrenKathy Pritchard-Jones, Norbert Graf, Harm van Tinteren, et al.
Pediatric Blood & Cancer|March 31, 2006
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trialChristine Juergens, Claire Weston, Ian Lewis, et al.
BMJ (Clinical Research Ed.)|March 10, 2011
Improving child health services in the UK: insights from Europe and their implications for the NHS reformsIngrid Wolfe, Hilary Cass, Matthew J Thompson, et al.
Clinical Sarcoma Research|April 4, 2018
Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92Jeremy Whelan, Allan Hackshaw, Anne McTiernan, et al.
Mutation Research|March 26, 2003
Changes in the human mitochondrial genome after treatment of malignant diseaseTheresa M Wardell, Elaine Ferguson, Patrick F Chinnery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trialRuth Ladenstein, Ulrike Pötschger, Marie Cécile Le Deley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trialMarie-Cécile Le Deley, Michael Paulussen, Ian Lewis, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pediatric Blood & Cancer|May 10, 2017
Reply to reported missing founding member of the International Society of Paediatric Oncology …foundGiorgio Perilongo, Giulio D'Angio, Alan Craft, et al.
Pediatric Hematology and Oncology|February 3, 2012
Ewing sarcoma: clinical state-of-the-artJenny Potratz, Uta Dirksen, Heribert Jürgens, et al.
Pediatric Hematology and Oncology|February 7, 2012
Ewing sarcoma: biology-based therapeutic perspectivesJenny Potratz, Heribert Jürgens, Alan Craft, et al.
Archives of Disease in Childhood|March 8, 2016
Evidence for a delay in diagnosis of Wilms' tumour in the UK compared with Germany: implications for primary care for childrenKathy Pritchard-Jones, Norbert Graf, Harm van Tinteren, et al.
Pediatric Blood & Cancer|March 31, 2006
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trialChristine Juergens, Claire Weston, Ian Lewis, et al.
BMJ (Clinical Research Ed.)|March 10, 2011
Improving child health services in the UK: insights from Europe and their implications for the NHS reformsIngrid Wolfe, Hilary Cass, Matthew J Thompson, et al.
Clinical Sarcoma Research|April 4, 2018
Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92Jeremy Whelan, Allan Hackshaw, Anne McTiernan, et al.
Mutation Research|March 26, 2003
Changes in the human mitochondrial genome after treatment of malignant diseaseTheresa M Wardell, Elaine Ferguson, Patrick F Chinnery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trialRuth Ladenstein, Ulrike Pötschger, Marie Cécile Le Deley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trialMarie-Cécile Le Deley, Michael Paulussen, Ian Lewis, et al.
Pageof 3